Review





Similar Products

90
ATCC isosyntypes bpi 442837
Isosyntypes Bpi 442837, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/isosyntypes bpi 442837/product/ATCC
Average 90 stars, based on 1 article reviews
isosyntypes bpi 442837 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology atf3 knockdown
Fig. 3 <t>Atf3</t> is a key upstream target of mitochondrial transfer in regulating the expression of RAGs. (A) Schematic of the experiment. The expression of Atf3 in DRG cells was knocked down by injection of Atf3 siRNA in to L3/4/5 DRGs and electrotransfection. The non-targeting siRNA were employed as a control to Atf3 siRNA. The SNI models were constructed 2 days later. To construct the SNI model, the right thigh of each mouse was surgically exposed at the mid- thigh level to access the sciatic nerve. The sciatic nerve was then crushed with moderate force using a forceps for a duration of 10 s. For the non-targeting siRNA with mitochrondria injection therapy (non-targeting siRNA + Mito) and Atf3 siRNA with mitochrondria injection therapy (Atf3 siRNA + Mito) groups, 2 µL of mitochondria derived from 106 MSCs were injected into the crush sites of the injured nerves. The injured sciatic nerves were removed 4 days later. After fixation and clearing, the nerves were whole-mount stained utilizing primary anti-Tuj1 antibodies and fluorescent secondary antibodies, imaging by a fluorescence microscope; (B) Representative immunofluorescence images of whole-mount sciatic nerves in non-targeting siRNA, non-targeting siRNA + Mito, Atf3 siRNA and Atf3 siRNA + Mito groups (left). Quantification of the average length of the top 5 axons with the longest regeneration distance in each groups (right). (C) qPCR of the selected RAGs in DRG tissue from the above 4 groups. The mRNA expression was normalized against GAPDH. Data represent means ± SD. Statistically significant differences are indicated; n = 6; *P < 0.05, vs. Control
Atf3 Knockdown, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atf3 knockdown/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
atf3 knockdown - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology atf3 sirna
<t> ATF3 </t> expression is upregulated in ΔNp63 -overexpressing CECs.
Atf3 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atf3 sirna/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
atf3 sirna - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology atf3
Fig. 4. Metformin increases GDF15 levels via AMPK activation. (a) Gdf15 mRNA levels, and (b) GDF15 secreted into the culture medium in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h. (c) Gdf15 mRNA levels in C2C12 myotubes exposed to 0.5 mM metformin (Met) for 24, 48 or 72 h or (d) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (e) Gdf15 mRNA levels in C2C12 myotubes transfected with control (Ct) (scrambled) siRNA or <t>ATF3</t> siRNA and treated with 2 mM metformin for 24 h. (f) Atf3 mRNA levels in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h or (g) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (h) GDF15 mRNA levels in Huh-7 human hepatoma cells exposed to different concentrations of metformin (Met) for 24 h. (i) ATF3 mRNA levels in Huh-7 cells exposed to different concentrations of metformin (Met) for 24 h. (j) Gdf15 mRNA levels in mouse primary hepatocytes exposed to different concentrations of metformin (Met) for 24 h or (k) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (l) Gdf15 mRNA levels in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (m) Immunoblot analysis of GDF15, and total and phospho-AMPK in C2C12 in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (a,b,d-h) n = 5 per group. (c,i-l) n = 4 per group. Data are presented as the mean ± SEM. * *p < 0.01 and * **p < 0.001 vs. control. ###p < 0.001 vs. Ct siRNA + Met or Met.
Atf3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atf3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
atf3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sirna for atf3
Fig. 4. Metformin increases GDF15 levels via AMPK activation. (a) Gdf15 mRNA levels, and (b) GDF15 secreted into the culture medium in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h. (c) Gdf15 mRNA levels in C2C12 myotubes exposed to 0.5 mM metformin (Met) for 24, 48 or 72 h or (d) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (e) Gdf15 mRNA levels in C2C12 myotubes transfected with control (Ct) (scrambled) siRNA or <t>ATF3</t> siRNA and treated with 2 mM metformin for 24 h. (f) Atf3 mRNA levels in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h or (g) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (h) GDF15 mRNA levels in Huh-7 human hepatoma cells exposed to different concentrations of metformin (Met) for 24 h. (i) ATF3 mRNA levels in Huh-7 cells exposed to different concentrations of metformin (Met) for 24 h. (j) Gdf15 mRNA levels in mouse primary hepatocytes exposed to different concentrations of metformin (Met) for 24 h or (k) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (l) Gdf15 mRNA levels in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (m) Immunoblot analysis of GDF15, and total and phospho-AMPK in C2C12 in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (a,b,d-h) n = 5 per group. (c,i-l) n = 4 per group. Data are presented as the mean ± SEM. * *p < 0.01 and * **p < 0.001 vs. control. ###p < 0.001 vs. Ct siRNA + Met or Met.
Sirna For Atf3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna for atf3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
sirna for atf3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse atf3
Figure 7. The expression of GPX4 was regulated by <t>ATF3</t> in Pkd1 mutant renal epithelial cells. (A) qRT-PCR and Western blot analysis of ATF3 and GPX4 mRNA levels in PH2 and PN24 cells. n53 independent experiments. (B) qRT-PCR and Western blot anal- ysis of ATF3 and GPX4 mRNA levels in Pkd1 WT and Pkd1 null MEK cells. n53 independent experiments. (C) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from 3-month-old WT (n55) and Pkd1RC/RC mice (n55). (D) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1RC/RC mice treated with vehicle (n55) or erastin (n55). (E) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1flox/flox:Pkhd1-Cre mice treated with vehicle (n55) or Fer-1 (n55). (F) qRT-PCR and Western blot analysis of the expression of ATF3 and GPX4 in PN24 cells transfected with ATF3 siRNA and control siRNA. n53 independent experiments. (G and H) chromatin immunoprecipitation (ChIP) (G) and ChIP-qPCR (H) analysis indi- cated that ATF3 bound to the promoter of GPX4 in PN24 cells. Histone H3 was used as a positive control. Normal rabbit IgG was used as a negative control. Statistical data are presented as the mean6SEM.
Mouse Atf3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse atf3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mouse atf3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 3 Atf3 is a key upstream target of mitochondrial transfer in regulating the expression of RAGs. (A) Schematic of the experiment. The expression of Atf3 in DRG cells was knocked down by injection of Atf3 siRNA in to L3/4/5 DRGs and electrotransfection. The non-targeting siRNA were employed as a control to Atf3 siRNA. The SNI models were constructed 2 days later. To construct the SNI model, the right thigh of each mouse was surgically exposed at the mid- thigh level to access the sciatic nerve. The sciatic nerve was then crushed with moderate force using a forceps for a duration of 10 s. For the non-targeting siRNA with mitochrondria injection therapy (non-targeting siRNA + Mito) and Atf3 siRNA with mitochrondria injection therapy (Atf3 siRNA + Mito) groups, 2 µL of mitochondria derived from 106 MSCs were injected into the crush sites of the injured nerves. The injured sciatic nerves were removed 4 days later. After fixation and clearing, the nerves were whole-mount stained utilizing primary anti-Tuj1 antibodies and fluorescent secondary antibodies, imaging by a fluorescence microscope; (B) Representative immunofluorescence images of whole-mount sciatic nerves in non-targeting siRNA, non-targeting siRNA + Mito, Atf3 siRNA and Atf3 siRNA + Mito groups (left). Quantification of the average length of the top 5 axons with the longest regeneration distance in each groups (right). (C) qPCR of the selected RAGs in DRG tissue from the above 4 groups. The mRNA expression was normalized against GAPDH. Data represent means ± SD. Statistically significant differences are indicated; n = 6; *P < 0.05, vs. Control

Journal: Cell communication and signaling : CCS

Article Title: MSC-derived mitochondria promote axonal regeneration via Atf3 gene up-regulation by ROS induced DNA double strand breaks at transcription initiation region.

doi: 10.1186/s12964-024-01617-7

Figure Lengend Snippet: Fig. 3 Atf3 is a key upstream target of mitochondrial transfer in regulating the expression of RAGs. (A) Schematic of the experiment. The expression of Atf3 in DRG cells was knocked down by injection of Atf3 siRNA in to L3/4/5 DRGs and electrotransfection. The non-targeting siRNA were employed as a control to Atf3 siRNA. The SNI models were constructed 2 days later. To construct the SNI model, the right thigh of each mouse was surgically exposed at the mid- thigh level to access the sciatic nerve. The sciatic nerve was then crushed with moderate force using a forceps for a duration of 10 s. For the non-targeting siRNA with mitochrondria injection therapy (non-targeting siRNA + Mito) and Atf3 siRNA with mitochrondria injection therapy (Atf3 siRNA + Mito) groups, 2 µL of mitochondria derived from 106 MSCs were injected into the crush sites of the injured nerves. The injured sciatic nerves were removed 4 days later. After fixation and clearing, the nerves were whole-mount stained utilizing primary anti-Tuj1 antibodies and fluorescent secondary antibodies, imaging by a fluorescence microscope; (B) Representative immunofluorescence images of whole-mount sciatic nerves in non-targeting siRNA, non-targeting siRNA + Mito, Atf3 siRNA and Atf3 siRNA + Mito groups (left). Quantification of the average length of the top 5 axons with the longest regeneration distance in each groups (right). (C) qPCR of the selected RAGs in DRG tissue from the above 4 groups. The mRNA expression was normalized against GAPDH. Data represent means ± SD. Statistically significant differences are indicated; n = 6; *P < 0.05, vs. Control

Article Snippet: The siRNAs used for Atf3 knockdown and non-targeting control were sourced from Santa Cruz Biotechnology, Inc., Santa Cruz, CA (#SC-29,758 and #SC-37,007).

Techniques: Expressing, Injection, Control, Construct, Derivative Assay, Staining, Imaging, Fluorescence, Microscopy, Immunofluorescence

Fig. 4 Mitochondria promote the expression of ATF3 through ROS induced DSBs. Four days after constructing SNI models and administering mitochon drial injection therapy, the DRGs were surgically extracted and sectioned. The levels of reactive oxygen species (ROS) in the DRGs were evaluated using Hydrocyanine-Cy3 staining and relative fluorescence quantification among the Sham, SNI, SNI with mitochondrial injection therapy (SNI + Mito), and SNI with mitochondrial injection and oxidant scavenger N-acetylcysteine (NAC) treatment (SNI + Mito + NAC) groups. (A) Representative Hydrocyanine-Cy3 staining images of DRG tissue from the Sham, SNI, SNI + Mito and SNI + Mito + NAC groups (left). Relative quantification of Hydrocyanine-Cy3 fluorescence intensities of the above 4 groups. The levels of DNA double strand breaks and ATF3 protein expression in DRGs from the above 4 groups were detect by Western blot. (B) Western blot of protein expression levels of DSB markers of γ-H2AX and 53BP1, and ATF3 in DRGs from Sham, SNI, SNI + Mito and SNI + Mito + NAC groups (left). Densitometric analysis of the protein expression of γ-H2AX, 53BP1, and ATF3 among the above 4 groups (right). Protein expression was normalized against β-actin. Data represent means ± SD. Statistically significant differences are indicated; n = 3; *P < 0.05, vs. Control

Journal: Cell communication and signaling : CCS

Article Title: MSC-derived mitochondria promote axonal regeneration via Atf3 gene up-regulation by ROS induced DNA double strand breaks at transcription initiation region.

doi: 10.1186/s12964-024-01617-7

Figure Lengend Snippet: Fig. 4 Mitochondria promote the expression of ATF3 through ROS induced DSBs. Four days after constructing SNI models and administering mitochon drial injection therapy, the DRGs were surgically extracted and sectioned. The levels of reactive oxygen species (ROS) in the DRGs were evaluated using Hydrocyanine-Cy3 staining and relative fluorescence quantification among the Sham, SNI, SNI with mitochondrial injection therapy (SNI + Mito), and SNI with mitochondrial injection and oxidant scavenger N-acetylcysteine (NAC) treatment (SNI + Mito + NAC) groups. (A) Representative Hydrocyanine-Cy3 staining images of DRG tissue from the Sham, SNI, SNI + Mito and SNI + Mito + NAC groups (left). Relative quantification of Hydrocyanine-Cy3 fluorescence intensities of the above 4 groups. The levels of DNA double strand breaks and ATF3 protein expression in DRGs from the above 4 groups were detect by Western blot. (B) Western blot of protein expression levels of DSB markers of γ-H2AX and 53BP1, and ATF3 in DRGs from Sham, SNI, SNI + Mito and SNI + Mito + NAC groups (left). Densitometric analysis of the protein expression of γ-H2AX, 53BP1, and ATF3 among the above 4 groups (right). Protein expression was normalized against β-actin. Data represent means ± SD. Statistically significant differences are indicated; n = 3; *P < 0.05, vs. Control

Article Snippet: The siRNAs used for Atf3 knockdown and non-targeting control were sourced from Santa Cruz Biotechnology, Inc., Santa Cruz, CA (#SC-29,758 and #SC-37,007).

Techniques: Expressing, Injection, Staining, Fluorescence, Quantitative Proteomics, Western Blot, Control

Fig. 5 MSC-derived mitochondrial transfer mediates DSBs at the Atf3 gene transcription initiation region. To detect double-strand breaks (DSBs) in vari ous regions of the Atf3 gene, the ChIP-PCR assay was employed, utilizing γ-H2AX and 53BP1 antibodies along with primers targeting the Atf3 promoter, exon 2, and 3’UTR. (A-C) ChIP-PCR analysis of γ-H2AX binding to the Atf3 promoter (A), exon 2 (B) and 3’UTR (C) regions in the sham, SNI and SNI with mitochrondrial injection therapy (SNI + Mito) groups. (D-F) ChIP-PCR analysis of 53BP1 binding to the Atf3 promoter (D), exon 2 (E) and 3’UTR (F) regions in the sham, SNI and SNI + Mito groups

Journal: Cell communication and signaling : CCS

Article Title: MSC-derived mitochondria promote axonal regeneration via Atf3 gene up-regulation by ROS induced DNA double strand breaks at transcription initiation region.

doi: 10.1186/s12964-024-01617-7

Figure Lengend Snippet: Fig. 5 MSC-derived mitochondrial transfer mediates DSBs at the Atf3 gene transcription initiation region. To detect double-strand breaks (DSBs) in vari ous regions of the Atf3 gene, the ChIP-PCR assay was employed, utilizing γ-H2AX and 53BP1 antibodies along with primers targeting the Atf3 promoter, exon 2, and 3’UTR. (A-C) ChIP-PCR analysis of γ-H2AX binding to the Atf3 promoter (A), exon 2 (B) and 3’UTR (C) regions in the sham, SNI and SNI with mitochrondrial injection therapy (SNI + Mito) groups. (D-F) ChIP-PCR analysis of 53BP1 binding to the Atf3 promoter (D), exon 2 (E) and 3’UTR (F) regions in the sham, SNI and SNI + Mito groups

Article Snippet: The siRNAs used for Atf3 knockdown and non-targeting control were sourced from Santa Cruz Biotechnology, Inc., Santa Cruz, CA (#SC-29,758 and #SC-37,007).

Techniques: Derivative Assay, Binding Assay, Injection

Fig. 6 MSC-derived mitochondria-mediated DSBs are close to the CTCF binding site. To investigate the positional correlation between mitochondria- mediated double-strand breaks (DSBs) and CTCF binding sites, dorsal root ganglions (DRGs) were isolated from sham and SNI with mitochrondrial injec tion therapy (SNI + Mito) groups, and γH2AX ChIP-seq as well as immunoprecipitation were employed. (A) UCSC genome browser views denoting the disposition of γH2AX signals at Atf3 under the sham and SNI with mitochrondrial injection therapy (SNI + Mito). (B) The plot denotes the disposition of input-normalized γ-H2AX signals relative to CTCF sites that displayed γ-H2AX peaks in their vicinity. The dashed line denotes the profile of γ-H2AX in the sham group, whereas the solid line indicates γ-H2AX profiles in the SNI with mitochrondrial injection therapy (SNI + Mito) group. (C) DRGs from the sham and SNI + Mito groups were lysed and γ-H2AX was immunoprecipitated. The precipitates were analyzed by western blotting with the γ-H2AX and CTCF antibodies

Journal: Cell communication and signaling : CCS

Article Title: MSC-derived mitochondria promote axonal regeneration via Atf3 gene up-regulation by ROS induced DNA double strand breaks at transcription initiation region.

doi: 10.1186/s12964-024-01617-7

Figure Lengend Snippet: Fig. 6 MSC-derived mitochondria-mediated DSBs are close to the CTCF binding site. To investigate the positional correlation between mitochondria- mediated double-strand breaks (DSBs) and CTCF binding sites, dorsal root ganglions (DRGs) were isolated from sham and SNI with mitochrondrial injec tion therapy (SNI + Mito) groups, and γH2AX ChIP-seq as well as immunoprecipitation were employed. (A) UCSC genome browser views denoting the disposition of γH2AX signals at Atf3 under the sham and SNI with mitochrondrial injection therapy (SNI + Mito). (B) The plot denotes the disposition of input-normalized γ-H2AX signals relative to CTCF sites that displayed γ-H2AX peaks in their vicinity. The dashed line denotes the profile of γ-H2AX in the sham group, whereas the solid line indicates γ-H2AX profiles in the SNI with mitochrondrial injection therapy (SNI + Mito) group. (C) DRGs from the sham and SNI + Mito groups were lysed and γ-H2AX was immunoprecipitated. The precipitates were analyzed by western blotting with the γ-H2AX and CTCF antibodies

Article Snippet: The siRNAs used for Atf3 knockdown and non-targeting control were sourced from Santa Cruz Biotechnology, Inc., Santa Cruz, CA (#SC-29,758 and #SC-37,007).

Techniques: Derivative Assay, Binding Assay, Isolation, ChIP-sequencing, Immunoprecipitation, Injection, Western Blot

Fig. 7 Diagrammatic depiction of the therapeutic effect of MSC-derived mitochondria injection therapy on sciatic nerve injury. MSC-derived mitochon dria are retrogradely transferred to DRG neurons via axoplasmic transport, and DSBs at the transcription initiation region of the Atf3 gene are mediated by ROS accumulation, thereby rapidly releasing topological constraints on chromatin interactions, facilitating spatial interactions between enhancers and Atf3 promoters, and promoting Atf3 expression, thus promoting the expression of genes related to regeneration, and finally, promoting axon regeneration

Journal: Cell communication and signaling : CCS

Article Title: MSC-derived mitochondria promote axonal regeneration via Atf3 gene up-regulation by ROS induced DNA double strand breaks at transcription initiation region.

doi: 10.1186/s12964-024-01617-7

Figure Lengend Snippet: Fig. 7 Diagrammatic depiction of the therapeutic effect of MSC-derived mitochondria injection therapy on sciatic nerve injury. MSC-derived mitochon dria are retrogradely transferred to DRG neurons via axoplasmic transport, and DSBs at the transcription initiation region of the Atf3 gene are mediated by ROS accumulation, thereby rapidly releasing topological constraints on chromatin interactions, facilitating spatial interactions between enhancers and Atf3 promoters, and promoting Atf3 expression, thus promoting the expression of genes related to regeneration, and finally, promoting axon regeneration

Article Snippet: The siRNAs used for Atf3 knockdown and non-targeting control were sourced from Santa Cruz Biotechnology, Inc., Santa Cruz, CA (#SC-29,758 and #SC-37,007).

Techniques: Derivative Assay, Injection, Expressing

 ATF3  expression is upregulated in ΔNp63 -overexpressing CECs.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ATF3 expression is upregulated in ΔNp63 -overexpressing CECs.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Expressing

ΔNp63 upregulates ATF3 expression in CECs. ( A ) Human CECs were infected with Ad- ΔNp63 or Ad- GFP (control) for 6 h. Cells were harvested 2 days after infection, and total RNA was extracted to analyze the mRNA expression level of the genes; ( B ) Human CECs were treated with si- ΔNp63 , Ad- ΔNp63 , or control plasmids (si-control + Ad- GFP ). The Cells were harvested 2 days after transfection, and the cell lysates were used to assess the protein levels of ΔNp63 and ATF3 via western blot analysis. ** p < 0.01 versus control.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ΔNp63 upregulates ATF3 expression in CECs. ( A ) Human CECs were infected with Ad- ΔNp63 or Ad- GFP (control) for 6 h. Cells were harvested 2 days after infection, and total RNA was extracted to analyze the mRNA expression level of the genes; ( B ) Human CECs were treated with si- ΔNp63 , Ad- ΔNp63 , or control plasmids (si-control + Ad- GFP ). The Cells were harvested 2 days after transfection, and the cell lysates were used to assess the protein levels of ΔNp63 and ATF3 via western blot analysis. ** p < 0.01 versus control.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Expressing, Infection, Control, Transfection, Western Blot

ΔNp63 increases ATF3 promoter activity in CECs. ( A ) The p63-binding sites in the human ATF3 promoter region (−1249 to +12) were deduced using p63 motif analysis software (p63scan algorithm). Position weight matrices (matrix sites) were matched to identify p63 motifs (−1044 to −1025); ( B ) Human (HuLmP1) or rabbit (RbLmP1) CECs were co-transfected with β-gal plasmids (a transfection control) and either pGL3-Basic, wt-Hu ATF3 , del-Hu ATF3 , wt-Hu ATF3 +Ad- ΔNp63 or del-Hu ATF3 +Ad- ΔNp63 for 16 h. After 48 h of transfection, the cells were harvested and their luciferase activity and β-gal activity were measured. ** p < 0.01.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ΔNp63 increases ATF3 promoter activity in CECs. ( A ) The p63-binding sites in the human ATF3 promoter region (−1249 to +12) were deduced using p63 motif analysis software (p63scan algorithm). Position weight matrices (matrix sites) were matched to identify p63 motifs (−1044 to −1025); ( B ) Human (HuLmP1) or rabbit (RbLmP1) CECs were co-transfected with β-gal plasmids (a transfection control) and either pGL3-Basic, wt-Hu ATF3 , del-Hu ATF3 , wt-Hu ATF3 +Ad- ΔNp63 or del-Hu ATF3 +Ad- ΔNp63 for 16 h. After 48 h of transfection, the cells were harvested and their luciferase activity and β-gal activity were measured. ** p < 0.01.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Activity Assay, Binding Assay, Software, Transfection, Control, Luciferase

ΔNp63 induces cell proliferation through an ATF3-dependent pathway. ( A ) Rabbit CECs were transfected with pCMV- ATF3 or control plasmids for 16 h. After transfection, cells were harvested and counted on days 1, 2, 3, and 4; ( B ) Cells were harvested on day 4 and analyzed for proliferation via BrdU assay and Ki-67 staining. Scale bar: 100 μm; ( C ) Ad- ΔNp63 -infected rabbit CECs were transfected with si- ATF3 or si-control for 16 h. Cells were harvested and counted on days 1, 2, 3, and 4 after transfection. ** p < 0.01.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ΔNp63 induces cell proliferation through an ATF3-dependent pathway. ( A ) Rabbit CECs were transfected with pCMV- ATF3 or control plasmids for 16 h. After transfection, cells were harvested and counted on days 1, 2, 3, and 4; ( B ) Cells were harvested on day 4 and analyzed for proliferation via BrdU assay and Ki-67 staining. Scale bar: 100 μm; ( C ) Ad- ΔNp63 -infected rabbit CECs were transfected with si- ATF3 or si-control for 16 h. Cells were harvested and counted on days 1, 2, 3, and 4 after transfection. ** p < 0.01.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Transfection, Control, BrdU Staining, Staining, Infection

ATF3 regulates the expression of cell-cycle–related genes in CECs. ( A ) Human CECs were transfected with pCMV- ATF3 or control plasmids for 48 h. After transfection, the cells were harvested, and the expression of cell-cycle–related genes was analyzed by qRT-PCR; ( B ) Human CECs were transfected with pCMV- ATF3 or control plasmids for 16 h. Cells were harvested on day 4 after transfection and assessed for cyclin D1 and p27 KipP1 protein expression via western blot analysis. ** p < 0.01.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ATF3 regulates the expression of cell-cycle–related genes in CECs. ( A ) Human CECs were transfected with pCMV- ATF3 or control plasmids for 48 h. After transfection, the cells were harvested, and the expression of cell-cycle–related genes was analyzed by qRT-PCR; ( B ) Human CECs were transfected with pCMV- ATF3 or control plasmids for 16 h. Cells were harvested on day 4 after transfection and assessed for cyclin D1 and p27 KipP1 protein expression via western blot analysis. ** p < 0.01.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Expressing, Transfection, Control, Quantitative RT-PCR, Western Blot

ATF3 did not alter the expression of keratinocyte differentiation-related proteins in human CECs. Human CECs were transfected with pCMV- ATF3 , si- ATF3 , or control plasmids for 16 h. Cells were harvested on day 4 after transfection and assessed for the expression of keratinocyte-differentiation–related proteins via western blot analysis.

Journal: Journal of Personalized Medicine

Article Title: Transcription Factor ATF3 Participates in DeltaNp63-Mediated Proliferation of Corneal Epithelial Cells

doi: 10.3390/jpm13040700

Figure Lengend Snippet: ATF3 did not alter the expression of keratinocyte differentiation-related proteins in human CECs. Human CECs were transfected with pCMV- ATF3 , si- ATF3 , or control plasmids for 16 h. Cells were harvested on day 4 after transfection and assessed for the expression of keratinocyte-differentiation–related proteins via western blot analysis.

Article Snippet: ATF3 siRNA (si- ATF3 ) was purchased from Santa Cruz Biotechnology (sc-29757; Santa Cruz, CA, USA).

Techniques: Expressing, Transfection, Control, Western Blot

Fig. 4. Metformin increases GDF15 levels via AMPK activation. (a) Gdf15 mRNA levels, and (b) GDF15 secreted into the culture medium in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h. (c) Gdf15 mRNA levels in C2C12 myotubes exposed to 0.5 mM metformin (Met) for 24, 48 or 72 h or (d) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (e) Gdf15 mRNA levels in C2C12 myotubes transfected with control (Ct) (scrambled) siRNA or ATF3 siRNA and treated with 2 mM metformin for 24 h. (f) Atf3 mRNA levels in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h or (g) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (h) GDF15 mRNA levels in Huh-7 human hepatoma cells exposed to different concentrations of metformin (Met) for 24 h. (i) ATF3 mRNA levels in Huh-7 cells exposed to different concentrations of metformin (Met) for 24 h. (j) Gdf15 mRNA levels in mouse primary hepatocytes exposed to different concentrations of metformin (Met) for 24 h or (k) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (l) Gdf15 mRNA levels in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (m) Immunoblot analysis of GDF15, and total and phospho-AMPK in C2C12 in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (a,b,d-h) n = 5 per group. (c,i-l) n = 4 per group. Data are presented as the mean ± SEM. * *p < 0.01 and * **p < 0.001 vs. control. ###p < 0.001 vs. Ct siRNA + Met or Met.

Journal: Pharmacological research

Article Title: A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.

doi: 10.1016/j.phrs.2022.106578

Figure Lengend Snippet: Fig. 4. Metformin increases GDF15 levels via AMPK activation. (a) Gdf15 mRNA levels, and (b) GDF15 secreted into the culture medium in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h. (c) Gdf15 mRNA levels in C2C12 myotubes exposed to 0.5 mM metformin (Met) for 24, 48 or 72 h or (d) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (e) Gdf15 mRNA levels in C2C12 myotubes transfected with control (Ct) (scrambled) siRNA or ATF3 siRNA and treated with 2 mM metformin for 24 h. (f) Atf3 mRNA levels in C2C12 myotubes exposed to different concentrations of metformin (Met) for 24 h or (g) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (h) GDF15 mRNA levels in Huh-7 human hepatoma cells exposed to different concentrations of metformin (Met) for 24 h. (i) ATF3 mRNA levels in Huh-7 cells exposed to different concentrations of metformin (Met) for 24 h. (j) Gdf15 mRNA levels in mouse primary hepatocytes exposed to different concentrations of metformin (Met) for 24 h or (k) transfected with control (Ct) (scrambled) siRNA or AMPKα1/α2 siRNA and treated with 2 mM metformin for 24 h. (l) Gdf15 mRNA levels in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (m) Immunoblot analysis of GDF15, and total and phospho-AMPK in C2C12 in mouse primary culture of hepatocytes exposed to 2 mM metformin (Met) for 24 h in the presence or absence of 30 µM compound C (Comp C). (a,b,d-h) n = 5 per group. (c,i-l) n = 4 per group. Data are presented as the mean ± SEM. * *p < 0.01 and * **p < 0.001 vs. control. ###p < 0.001 vs. Ct siRNA + Met or Met.

Article Snippet: Differentiated myotubes were transiently transfected with 70 nM of siRNA against AMPK1/2 (Santa Cruz Biotechnology Inc., catalog sc45313), GDF15 (Santa Cruz Biotechnology Inc., catalog sc-39799), p53 (Santa Cruz Biotechnology Inc., catalog sc-29436), ATF3 (Santa Cruz Biotechnology Inc., catalog sc-29758), or control siRNA (Santa Cruz Biotechnology Inc., catalog sc-37007) in Opti-MEM medium (Thermo Fisher, MA), using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) (7 μl per 1.5-mL well) according to the manufacturer’s instructions.

Techniques: Activation Assay, Transfection, Control, Western Blot

Figure 7. The expression of GPX4 was regulated by ATF3 in Pkd1 mutant renal epithelial cells. (A) qRT-PCR and Western blot analysis of ATF3 and GPX4 mRNA levels in PH2 and PN24 cells. n53 independent experiments. (B) qRT-PCR and Western blot anal- ysis of ATF3 and GPX4 mRNA levels in Pkd1 WT and Pkd1 null MEK cells. n53 independent experiments. (C) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from 3-month-old WT (n55) and Pkd1RC/RC mice (n55). (D) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1RC/RC mice treated with vehicle (n55) or erastin (n55). (E) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1flox/flox:Pkhd1-Cre mice treated with vehicle (n55) or Fer-1 (n55). (F) qRT-PCR and Western blot analysis of the expression of ATF3 and GPX4 in PN24 cells transfected with ATF3 siRNA and control siRNA. n53 independent experiments. (G and H) chromatin immunoprecipitation (ChIP) (G) and ChIP-qPCR (H) analysis indi- cated that ATF3 bound to the promoter of GPX4 in PN24 cells. Histone H3 was used as a positive control. Normal rabbit IgG was used as a negative control. Statistical data are presented as the mean6SEM.

Journal: Journal of the American Society of Nephrology

Article Title: Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models

doi: 10.1681/asn.2021040460

Figure Lengend Snippet: Figure 7. The expression of GPX4 was regulated by ATF3 in Pkd1 mutant renal epithelial cells. (A) qRT-PCR and Western blot analysis of ATF3 and GPX4 mRNA levels in PH2 and PN24 cells. n53 independent experiments. (B) qRT-PCR and Western blot anal- ysis of ATF3 and GPX4 mRNA levels in Pkd1 WT and Pkd1 null MEK cells. n53 independent experiments. (C) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from 3-month-old WT (n55) and Pkd1RC/RC mice (n55). (D) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1RC/RC mice treated with vehicle (n55) or erastin (n55). (E) qRT-PCR and Western blot analysis of the expression of ATF3 in kidneys from Pkd1flox/flox:Pkhd1-Cre mice treated with vehicle (n55) or Fer-1 (n55). (F) qRT-PCR and Western blot analysis of the expression of ATF3 and GPX4 in PN24 cells transfected with ATF3 siRNA and control siRNA. n53 independent experiments. (G and H) chromatin immunoprecipitation (ChIP) (G) and ChIP-qPCR (H) analysis indi- cated that ATF3 bound to the promoter of GPX4 in PN24 cells. Histone H3 was used as a positive control. Normal rabbit IgG was used as a negative control. Statistical data are presented as the mean6SEM.

Article Snippet: RNA Interference The RNA oligonucleotides that specifically targeted mouse ATF3 were purchased from Santa Cruz Biotechnology Inc, and were transfected with Dharma-FECT siRNA transfection reagent (Dharmacon).

Techniques: Expressing, Mutagenesis, Quantitative RT-PCR, Western Blot, Transfection, Control, Chromatin Immunoprecipitation, ChIP-qPCR, Positive Control, Negative Control

Figure 8. Working model of ferroptosis in regulation of cyst growth in ADPKD. A schematic diagram depicting ferroptosis asso- ciated pathways and processes in Pkd1 mutant renal epithelial cells and kidneys. Pkd1 mutation or erastin treatment (1) decreased system Xc2 and resulted in the reduction of cystine uptake and the depletion of GSH, leading to inactivate GPX4 enzymatic activity and then increase lipid peroxidation, and (2) increased the expression of multiple iron regulatory proteins (IRPs), including TFR1, FTH1, DMT1, Fpn, and HO-1 and resulted in the increase of the import of HO-1–mediated nonheme iron and the storage of iron in Pkd1 mutant renal epithelial cells to increase lipid peroxidation, both of these processes leading to ferroptosis. The excess lipid per- oxidation also stimulated the expression of ATF3, which repressed the expression of SLC7A11 and GPX4, forming a feedback loop of lipid peroxidation–ATF3–SLC7A11/GPX4–lipid peroxidation, and increased the production of 4HNE-protein adducts. Upregulation of 4HNE (1) promotes Pkd1 mutant cell proliferation via activation of Akt, S6, Stat3, and Rb, and (2) upregulates the expression of HO-1, which regulates the release of heme iron and results in its import and storage in Pkd1 mutant renal epithelial cells to promote ferroptosis. All these 4HNE-mediated processes can be inhibited by L-carnosine. In addition, treatment with Fer-1, a ferroptosis inhibitor, delays cyst growth in early stage and long-lasting Pkd1 animal models, which highlights a novel therapeutic strategy for ADPKD treatment.

Journal: Journal of the American Society of Nephrology

Article Title: Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models

doi: 10.1681/asn.2021040460

Figure Lengend Snippet: Figure 8. Working model of ferroptosis in regulation of cyst growth in ADPKD. A schematic diagram depicting ferroptosis asso- ciated pathways and processes in Pkd1 mutant renal epithelial cells and kidneys. Pkd1 mutation or erastin treatment (1) decreased system Xc2 and resulted in the reduction of cystine uptake and the depletion of GSH, leading to inactivate GPX4 enzymatic activity and then increase lipid peroxidation, and (2) increased the expression of multiple iron regulatory proteins (IRPs), including TFR1, FTH1, DMT1, Fpn, and HO-1 and resulted in the increase of the import of HO-1–mediated nonheme iron and the storage of iron in Pkd1 mutant renal epithelial cells to increase lipid peroxidation, both of these processes leading to ferroptosis. The excess lipid per- oxidation also stimulated the expression of ATF3, which repressed the expression of SLC7A11 and GPX4, forming a feedback loop of lipid peroxidation–ATF3–SLC7A11/GPX4–lipid peroxidation, and increased the production of 4HNE-protein adducts. Upregulation of 4HNE (1) promotes Pkd1 mutant cell proliferation via activation of Akt, S6, Stat3, and Rb, and (2) upregulates the expression of HO-1, which regulates the release of heme iron and results in its import and storage in Pkd1 mutant renal epithelial cells to promote ferroptosis. All these 4HNE-mediated processes can be inhibited by L-carnosine. In addition, treatment with Fer-1, a ferroptosis inhibitor, delays cyst growth in early stage and long-lasting Pkd1 animal models, which highlights a novel therapeutic strategy for ADPKD treatment.

Article Snippet: RNA Interference The RNA oligonucleotides that specifically targeted mouse ATF3 were purchased from Santa Cruz Biotechnology Inc, and were transfected with Dharma-FECT siRNA transfection reagent (Dharmacon).

Techniques: Mutagenesis, Activity Assay, Expressing, Activation Assay